Skip to main content

Amoxicillin and Clavulanate Oral Presentations Shortage

Last Updated: May 6, 2025
Status: Current

Products Affected - Description
    • Amoxicillin and Clavulanate oral powder for suspension, Sandoz, 200 mg/5 mL - 28.5 mg/5 mL, 50 mL bottle, 1 count, NDC 00781-6102-52
    • Amoxicillin and Clavulanate oral powder for suspension, Sandoz, 400 mg/5 mL - 57 mg/5 mL, 75 mL bottle, 1 count, NDC 00781-6104-57
    • Amoxicillin and Clavulanate oral powder for suspension, Sandoz, 600 mg/5 mL - 42.9 mg/5 mL, 75 mL bottle, 1 count, NDC 00781-6139-57
    • Amoxicillin and Clavulanate oral powder for suspension, Teva, 400 mg/5 mL - 57 mg/5 mL, 100 mL bottle, 1 count, NDC 00093-2279-73
    • Amoxicillin and Clavulanate oral powder for suspension, Teva, 600 mg/5 mL - 42.9 mg/5 mL, 125 mL bottle, 1 count, NDC 00093-8675-75
    • Amoxicillin and Clavulanate oral powder for suspension, Teva, 600 mg/5 mL - 42.9 mg/5 mL, 75 mL bottle, 1 count, NDC 00093-8675-78
    • Amoxicillin and Clavulanate oral tablet, Teva, 200 mg/28.5 mg, 20 count, NDC 00093-2270-34
    • Amoxicillin and Clavulanate oral tablet, Teva, 400 mg/57 mg, 20 count, NDC 00093-2272-34
    • Amoxicillin and Clavulanate oral powder for suspension, Wockhardt USA, 250 mg/5 mL - 62.5 mg/5 mL, 100 mL bottle, 1 count, NDC 60432-0065-00 - discontinued
    • Amoxicillin and Clavulanate oral powder for suspension, Wockhardt USA, 250 mg/5 mL - 62.5 mg/5 mL, 150 mL bottle, 1 count, NDC 60432-0065-47 - discontinued
    • Amoxicillin and Clavulanate oral powder for suspension, Wockhardt USA, 250 mg/5 mL - 62.5 mg/5 mL, 75 mL bottle, 1 count, NDC 60432-0065-75 - discontinued
Reason for the Shortage
    • Aurobindo refuses to provide availability information.
    • Hikma has amoxicillin and clavulanate oral presentations available.
    • Micro Labs was not available to provide information.
    • Sandoz did not provide a reason for the shortage.
    • Teva did not provide a reason for the shortage.
    • US Antibiotics has amoxicillin and clavulanate oral suspension available.
    • Wockhardt discontinued amoxicillin and clavulanate oral presentations in October 2024.
Available Products
    • Amoxicillin and Clavulanate oral powder for suspension, Hikma, 200 mg/5 mL - 28.5 mg/5 mL, 100 mL bottle, 1 count, NDC 00143-9981-01
    • Amoxicillin and Clavulanate oral powder for suspension, Hikma, 200 mg/5 mL - 28.5 mg/5 mL, 50 mL bottle, 1 count, NDC 00143-9981-50
    • Amoxicillin and Clavulanate oral powder for suspension, Hikma, 200 mg/5 mL - 28.5 mg/5 mL, 75 mL bottle, 1 count, NDC 00143-9981-75
    • Amoxicillin and Clavulanate oral powder for suspension, Hikma, 400 mg/5 mL - 57 mg/5 mL, 100 mL bottle, 1 count, NDC 00143-9982-01
    • Amoxicillin and Clavulanate oral powder for suspension, Hikma, 400 mg/5 mL - 57 mg/5 mL, 50 mL bottle, 1 count, NDC 00143-9982-50
    • Amoxicillin and Clavulanate oral powder for suspension, Hikma, 400 mg/5 mL - 57 mg/5 mL, 75 mL bottle, 1 count, NDC 00143-9982-75
    • Amoxicillin and Clavulanate oral powder for suspension, Hikma, 600 mg/5 mL - 42.9 mg/5 mL, 125 mL bottle, 1 count, NDC 00143-9853-16
    • Amoxicillin and Clavulanate oral powder for suspension, Hikma, 600 mg/5 mL - 42.9 mg/5 mL, 200 mL bottle, 1 count, NDC 00143-9853-24
    • Amoxicillin and Clavulanate oral powder for suspension, Hikma, 600 mg/5 mL - 42.9 mg/5 mL, 75 mL bottle, 1 count, NDC 00143-9853-75
    • Amoxicillin and Clavulanate oral tablet, Hikma, 875 mg/125 mg, 20 count, NDC 00143-9249-20
    • Amoxicillin and Clavulanate oral extended release tablet, Sandoz, 1000 mg / 62.5 mg, 28 count, NDC 00781-1943-82
    • Amoxicillin and Clavulanate oral extended release tablet, Sandoz, 1000 mg / 62.5 mg, 40 count, NDC 00781-1943-39
    • Amoxicillin and Clavulanate oral powder for suspension, Sandoz, 200 mg/5 mL - 28.5 mg/5 mL, 100 mL bottle, 1 count, NDC 00781-6102-46
    • Amoxicillin and Clavulanate oral powder for suspension, Sandoz, 200 mg/5 mL - 28.5 mg/5 mL, 75 mL bottle, 1 count, NDC 00781-6102-57
    • Amoxicillin and Clavulanate oral powder for suspension, Sandoz, 400 mg/5 mL - 57 mg/5 mL, 100 mL bottle, 1 count, NDC 00781-6104-46
    • Amoxicillin and Clavulanate oral powder for suspension, Sandoz, 400 mg/5 mL - 57 mg/5 mL, 50 mL bottle, 1 count, NDC 00781-6104-52
    • Amoxicillin and Clavulanate oral powder for suspension, Sandoz, 600 mg/5 mL - 42.9 mg/5 mL, 125 mL bottle, 1 count, NDC 00781-6139-54
    • Amoxicillin and Clavulanate oral powder for suspension, Sandoz, 600 mg/5 mL - 42.9 mg/5 mL, 200 mL bottle, 1 count, NDC 00781-6139-48
    • Amoxicillin and Clavulanate oral tablet, Sandoz, 250 mg / 125 mg, 30 count, NDC 00781-1874-31
    • Amoxicillin and Clavulanate oral tablet, Sandoz, 500 mg / 125 mg, 20 count, NDC 00781-1831-20
    • Amoxicillin and Clavulanate oral tablet, Sandoz, 500 mg / 125 mg, 100 count, NDC 00781-1831-01
    • Amoxicillin and Clavulanate oral tablet, Sandoz, 875 mg / 125 mg, 20 count, NDC 00781-1852-20
    • Amoxicillin and Clavulanate oral tablet, Sandoz, 875 mg / 125 mg, 100 count, NDC 00781-1852-01
    • Amoxicillin and Clavulanate oral powder for suspension, Teva, 200 mg/5 mL - 28.5 mg/5 mL, 100 mL bottle, 1 count, NDC 00093-2277-73
    • Amoxicillin and Clavulanate oral powder for suspension, Teva, 600 mg/5 mL - 42.9 mg/5 mL, 200 mL bottle, 1 count, NDC 00093-8675-74
    • Amoxicillin and Clavulanate oral tablet, Teva, 500 mg/125 mg, 20 count, NDC 00093-2274-34
    • Amoxicillin and Clavulanate oral tablet, Teva, 875 mg/125 mg, 20 count, NDC 00093-2275-34
    • Amoxicillin and Clavulanate oral powder for suspension, US Antibiotics, 600 mg/5 mL - 42.9 mg/5 mL, 125 mL bottle, 1 count, NDC 81964-0206-69
    • Amoxicillin and Clavulanate oral powder for suspension, US Antibiotics, 600 mg/5 mL - 42.9 mg/5 mL, 200 mL bottle, 1 count, NDC 81964-0203-54
    • Amoxicillin and Clavulanate oral powder for suspension, US Antibiotics, 600 mg/5 mL - 42.9 mg/5 mL, 75 mL bottle, 1 count, NDC 81964-0203-51

Estimated Resupply Dates

    • Sandoz has amoxicillin and clavulanate 400 mg/5 mL - 57 mg/5 mL in 50 mL and 75 mL oral powder for suspension on intermittent back order and the company is releasing supplies as they become available. The 600 mg/5 mL - 42.9 mg/5 mL in 75 mL bottles are also on intermittent back order and the company is releasing supplies as they become available.
    • Teva has amoxicillin and clavulanate 400 mg/5 mL - 57 mg/5 mL in 100 mL bottles on back order and the company estimates a release date of early-June 2025. The 600 mg/5 mL - 42.9 mg/5 mL in 75 mL and 125 mL bottles are on intermittent back order and the company is releasing supplies as they become available.

Updated

Updated May 6, 2025 by Leslie Jensen, PharmD, Drug Information Specialist. Created November 18, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer